Chronic Myelocytic Leukemia and Interferon: Pathophysiological, Clinical and Therapeutical Aspects

Cytogenetic Findings in Myeloproliferative Disorders.- Molecular Analyses of Chronic Myelocytic Leukemias.- Molecular Biological Investigation in Chronic Myelogenous Leukemia Patients Undergoing Interferon Therapie.- Effect of Recombinant Interferon-Alpha-2 on the Growth of Hematopoietic Progenitor Cells in Chronic Myelogenous Leukemia and Its Relationship to the Clinical Efficacy.- In Vitro Effects of Recombinant Human Tumor Necrosis Factor-Alpha and Interferon-Gamma on Normal and Leukemic Myelopoiesis.- Demonstration of Interferon-Alpha Receptors in Cultured Cell Lines and in Myeloid Cells from Patients with Acute or Chronic Myeloid Leukemia.- Differential Regulation of Cell Membrane Receptors for Interferon-Gamma and -Alpha on Peripheral Blood Cells of Patients with Chronic Myelogenous Leukemia During Interferon-Gamma/-Alpha Therapy.- Studies of Interferon as a Regulator on Hematopoietic Stem Cells in Chronic Myelogenous Leukemia.- Suppressive Effect of Interferon Alpha-2b on Hematopoietic Progenitor Cells in Patients with Chronic Myelogenous Leukemia.- Clinical Significance of Neutralizing Antibodies in Patients with Chronic Myelogenic Leukemia.- Cytostatic Therapy of Chronic Myelogenous Leukemia: Review and Perspectives.- In Vivo Effects of Interferon-gamma in Chronic Myelogenous Leukemia.- Treatment of Chronic and Acute Phase Chronic Myelogenous Leukemia with Interferon-Alpha-2b and Interferon-?.- Maintenance Therapy of Busulfan-Induced Chronic Granulocytic Leukemia Remissions with Interferon-Alpha-2b.- Allogeneic Bone Marrow Transplantation in Chronic Myelogenous Leukemia.